Peripheral blood immunoinflammatory biomarkers: prospective predictors of postoperative long-term survival and chronic postsurgical pain in breast cancer
Elevated preoperative SIRI was an independent risk factor for poor DFS in breast cancer patients after surgery. In contrast, perioperative immunoinflammatory biomarkers had limited potential for predicting CPSP in patients who underwent breast cancer surgery.
Authors
- Bin Ai (ORCID: https://orcid.org/0000-0001-7257-751X)
- Peixin Tan
- Jingpu Yang (ORCID: https://orcid.org/0000-0003-2816-478X)
- Bingbing Fu (ORCID: https://orcid.org/0000-0002-9122-0708)
- Min Fan (ORCID: https://orcid.org/0000-0002-2639-2415)
- Yi Fang (ORCID: https://orcid.org/0000-0002-2657-0146)
- Hui Zheng (ORCID: https://orcid.org/0000-0002-4325-4946)
- Li Che
- Timothy C. Wang (ORCID: https://orcid.org/0000-0001-5730-3019)
- Huixian Li (ORCID: https://orcid.org/0000-0002-3713-8017)
- Linxin Wu (ORCID: https://orcid.org/0000-0002-9580-4516)
- Tao Yan (ORCID: https://orcid.org/0000-0001-8937-353X)
- Baoli Li (ORCID: https://orcid.org/0009-0009-4797-1318)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Dalian University of Technology (CN)
- Dalian Municipal Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-01-29
- DOI
- https://doi.org/10.3389/fimmu.2025.1531639
- Citations
- 8
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 8.36
Funders
- Bethune Charitable Foundation
- National Natural Science Foundation of China
- Cancer Foundation of China